DRMA

Dermata Therapeutics Inc

• PUBT·06/16 20:16

  Dermata Therapeutics director Kathleen D. Scott disposes of 11 common shares worth $13.09

• TipRanks·05/27 22:09

  Dermata Therapeutics Shareholders Approve Equity Plan and Directors

• PUBT·05/27 20:58

  Dermata Therapeutics shareholders approved equity plan share increase to 402,214 at annual meeting

• Benzinga·05/26 21:06

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• TipRanks·05/19 19:45

  Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4

• Seeking Alpha·05/13 20:59

  Dermata Therapeutics GAAP EPS of -$0.48 beats by $0.05

• Reuters·04/07 10:01

  Dermata Therapeutics announces annual shareholder meeting webcast

• TipRanks·04/02 12:39

  Dermata receives notice of acceptance of Australian patent application

• Benzinga·04/02 12:38

  Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers

• Reuters·04/02 12:32

  Dermata says Australian patent application for topical dermal fillers accepted for Bioneedle system

• TipRanks·04/01 12:35

  Dermata Therapeutics price target lowered to $4 from $10 at Maxim

• Seeking Alpha·03/27 14:16

  Dermata Therapeutics GAAP EPS of -$8.16

• Reuters·03/26 21:18

  Dermata Therapeutics FY2025 net loss narrows 38.48% to $(7.6) million; operating expenses drop 37.87% to $7.8 million

• Reuters·03/26 21:17

  Dermata Therapeutics FY2025 net loss narrows 38.5% to $7.6 million; cash and cash equivalents climb 138% to $8 million

• Benzinga·03/20 17:06

  12 Health Care Stocks Moving In Friday's Intraday Session